fig2

New insights into acquired endocrine resistance of breast cancer

Figure 2. Signal transduction pathways differentially regulated by E2 and tamoxifen in tamoxifen-resistant model. E2 and tamoxifen (TAM) exert differential functions on nuclear estrogen receptor α (ERα). E2 activates classical ER-target genes but TAM acts to block gene activation. Both E2 and TAM increase the non-genomic activity of ERα through membrane-associated molecules such as extracellular matrix (ECM), c-Src, insulin-like growth factor-1 receptor (IGF-1R), and focal adhesion kinase (FAK) to enhance downstream signaling cascades, leading to acquired resistance[32]

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/